Laboratory News and Research

RSS

Horizon Discovery partners with St George’s University Hospital and EMQN to develop reference material for NIPT

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced it is collaborating with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, to develop reference material for non-invasive prenatal testing (NIPT).

From Revvity 26 Mar 2019

Improved TB Diagnostic Assay for Better Multiplexing from Bruker

In time for the World Tuberculosis (TB) Day 2019 on Sunday, March 24th, Bruker today announced the launch of an important further innovation in the field of tuberculosis diagnostics.

From Bruker BioSpin - NMR, EPR and Imaging 26 Mar 2019

Synthetic biological logic gate could one day be used to modify cellular function

Genes in living cells are activated - or not - by proteins called transcription factors. The mechanisms by which these proteins activate certain genes and deactivate others play a fundamental role in many biological processes.

26 Mar 2019

Aspirin could be used to treat patients with severe tuberculosis infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.

26 Mar 2019

Immune system errors linked to development of childhood leukemia

Genetic mutations that drive the development of a common type of childhood leukemia can be traced back to errors by the immune system during the production of antibodies.

25 Mar 2019

Sativa Investments completes 1000th cannabinoid and terpenes test at PhytoVista Laboratories

Sativa Investments PLC, the UK’s first medicinal cannabis investment vehicle, has completed its 1000th cannabinoid and terpenes test at its on-site testing facility, PhytoVista Laboratories (“PhytoVista”).

25 Mar 2019

Scientific Symposium at LABVOLUTION focuses on key issues in life sciences

The Scientific Symposium at LABVOLUTION will be focusing on key issues in the life sciences. Accordingly, a high level of visitor demand is anticipated.

From LABVOLUTION 25 Mar 2019

HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range

HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments.

From HORIBA Medical 25 Mar 2019

Shaping new treatments for tuberculosis

To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis.

25 Mar 2019

Surprising discovery offers clues to limit graft-vs.-host disease

A protein that protects people with inflammatory bowel disease has quite a different effect in graft-vs.-host disease, a common and challenging side effect of bone marrow transplants.

22 Mar 2019

Hidden differences between pathology of CTE and Alzheimer's disease discovered

An international team of scientists at Indiana University School of Medicine, University of Kansas and the U.K. Medical Research Council have dismantled the belief that Alzheimer's disease and Chronic Traumatic Encephalopathy have identical pathology.

22 Mar 2019

Repurposing drugs to outsmart cancers

In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.

22 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Air Force develops genetic test to predict mental performance

A research psychologist at the Air Force Research Laboratory can predict your mental performance from a cheek swab or blood sample.

22 Mar 2019

High-fructose corn syrup fuels growth of colon tumors in mice

Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

22 Mar 2019

Mobile health apps can pose unprecedented risk to consumers' privacy

Mobile health apps are a booming market targeted at both patients and health professionals. Medicines-related apps help patients track their prescriptions and remember to take their pills.

22 Mar 2019

New combination treatment shows promise for common brain tumor in children

A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models.

22 Mar 2019

Recent research shows that ease of breastfeeding after C-section differs culturally

The increase in cesarean sections is on the verge of a global epidemic. Though the World Health Organization recommends an optimal C-section rate of 10-15 percent, the United States' C-section rate is more than 30 percent.

22 Mar 2019

Open-source solution for multiparametric optical mapping of the heart's electrical activity

An international research team from the George Washington University, U.S., and the Moscow Institute of Physics and Technology, Russia, has developed an open-source solution for multiparametric optical mapping of the heart's electrical activity.

22 Mar 2019

TMJ disorders could be treated with tissue-engineered implants after successful animal study

It’s estimated that around 10 million Americans experience a temporomandibular joint (TMJ) disorder, with women being more susceptible than men. Affecting the jaw joint, TMJ disorders are characterized by pain around the jaw, ear, and temple, as well as difficulties in opening the mouth and significant clicking or grinding noises brought on by jaw movement.

21 Mar 2019